Evidence map›Paper›PMID 37316282›Full record

ArticleBMJ case reports2023

ST-elevation myocardial infarction after thrombolytic therapy with Tenecteplase for acute ischaemic stroke.

Jorge Enrique Sinclair, Marie Plante, Michael F Harrison, Devang K Sanghavi

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. [Analysis of the unicentric registry of the Infarction Code program: retrospective cohort].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jorge Enrique SinclairDepartment of Critical Care Medicine, Mayo Clinic in Florida, Jacksonville, Florida, USA.ORCID http://orcid.org/0000-0002-7556-8851
Marie PlanteDepartment of Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Michael F HarrisonDepartment of Emergency Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Devang K SanghaviDepartment of Critical Care Medicine, Mayo Clinic in Florida, Jacksonville, Florida, USA Sanghavi.Devang@mayo.edu.
Jacksonville College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial infarction (MI) secondary to thrombolytic therapy in the setting of acute ischaemic stroke (AIS) is a rare but severe complication. This phenomenon has been well documented in the past with recombinant tissue-type plasminogen activator, also known as Alteplase. However, there are no documented reports of MI secondary to Tenecteplase (TNKase), an alternative thrombolytic agent rapidly gaining favour in managing AIS. We report a male patient in his 50s who received TNKase for an AIS and subsequently developed an inferolateral ST elevation MI.

Indexed as

Brain IschemiaIschemic StrokeMyocardial InfarctionST Elevation Myocardial InfarctionStrokeHumansMaleTenecteplaseThrombolytic TherapyTenecteplaseAdult intensive careInterventional cardiologyStrokeUnwanted effects / adverse reactions

Identifiers

PMID37316282
PMCPMC10277056
OpenAlexW4380591235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.